FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108284306> ?p ?o ?g. }

• W2108284306 endingPage "599" @default.
• W2108284306 startingPage "590" @default.
• W2108284306 abstract "Recent attention to the increasing incidence of venous thromboembolism has included a call to action from the surgeon general and new guidelines from various specialty organizations. The standard of care for treatment of deep venous thrombosis in the emergency department (ED), supported by the 2008 American College of Chest Physicians (ACCP) guidelines, involves initiation of anticoagulation with low-molecular-weight heparin, pentasaccharide, or unfractionated heparin. For selected appropriate patients with extensive acute proximal deep venous thrombosis, the ACCP guidelines now recommend thrombolysis in addition to anticoagulation to reduce not only the risk of pulmonary embolism but also the risk of subsequent postthrombotic syndrome and recurrent deep venous thrombosis. Postthrombotic syndrome is a potentially debilitating chronic cluster of lower-extremity symptoms occurring in 20% to 50% of deep venous thrombosis patients subsequent to the acute insult, sometimes not until years later. A strategy of early thrombus burden reduction or frank removal might reduce the incidence of postthrombotic syndrome, as per natural history studies, venous thrombectomy data, observations after systemic and catheter-directed thrombolysis, and the still-limited number of randomized trials of catheter-directed thrombolysis (with anticoagulation) versus anticoagulation alone. Contemporary invasive (endovascular) treatments mitigate the drawbacks historically associated with thrombolytic approaches by means of intrathrombus delivery of drugs with greater fibrin specificity and lower allergenicity, followed by mechanical dispersion to accelerate lysis and then aspiration of remaining drug and clot debris. With a 2016 target completion date, the National Heart, Lung, and Blood Institute–sponsored Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis trial is comparing the safety and efficacy, in terms of both deep venous thrombosis and postthrombotic syndrome parameters, of the most evolved pharmacomechanical catheter-directed thrombolysis devices versus standard anticoagulation therapy alone. This article reviews the grounds for use of adjunctive thrombolysis in patients with acute proximal deep venous thrombosis and begins to identify types of deep venous thrombosis patients encountered in the ED who might benefit most from multidisciplinary consideration of early referral for possible endovascular therapy. Recent attention to the increasing incidence of venous thromboembolism has included a call to action from the surgeon general and new guidelines from various specialty organizations. The standard of care for treatment of deep venous thrombosis in the emergency department (ED), supported by the 2008 American College of Chest Physicians (ACCP) guidelines, involves initiation of anticoagulation with low-molecular-weight heparin, pentasaccharide, or unfractionated heparin. For selected appropriate patients with extensive acute proximal deep venous thrombosis, the ACCP guidelines now recommend thrombolysis in addition to anticoagulation to reduce not only the risk of pulmonary embolism but also the risk of subsequent postthrombotic syndrome and recurrent deep venous thrombosis. Postthrombotic syndrome is a potentially debilitating chronic cluster of lower-extremity symptoms occurring in 20% to 50% of deep venous thrombosis patients subsequent to the acute insult, sometimes not until years later. A strategy of early thrombus burden reduction or frank removal might reduce the incidence of postthrombotic syndrome, as per natural history studies, venous thrombectomy data, observations after systemic and catheter-directed thrombolysis, and the still-limited number of randomized trials of catheter-directed thrombolysis (with anticoagulation) versus anticoagulation alone. Contemporary invasive (endovascular) treatments mitigate the drawbacks historically associated with thrombolytic approaches by means of intrathrombus delivery of drugs with greater fibrin specificity and lower allergenicity, followed by mechanical dispersion to accelerate lysis and then aspiration of remaining drug and clot debris. With a 2016 target completion date, the National Heart, Lung, and Blood Institute–sponsored Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis trial is comparing the safety and efficacy, in terms of both deep venous thrombosis and postthrombotic syndrome parameters, of the most evolved pharmacomechanical catheter-directed thrombolysis devices versus standard anticoagulation therapy alone. This article reviews the grounds for use of adjunctive thrombolysis in patients with acute proximal deep venous thrombosis and begins to identify types of deep venous thrombosis patients encountered in the ED who might benefit most from multidisciplinary consideration of early referral for possible endovascular therapy." @default.
• W2108284306 created "2016-06-24" @default.
• W2108284306 creator A5048154042 @default.
• W2108284306 date "2011-06-01" @default.
• W2108284306 modified "2023-09-24" @default.
• W2108284306 title "Advanced Management of Acute Iliofemoral Deep Venous Thrombosis: Emergency Department and Beyond" @default.
• W2108284306 cites W1592091620 @default.
• W2108284306 cites W1968406183 @default.
• W2108284306 cites W1979441861 @default.
• W2108284306 cites W1981751049 @default.
• W2108284306 cites W1985770941 @default.
• W2108284306 cites W1989372279 @default.
• W2108284306 cites W1992206943 @default.
• W2108284306 cites W1993112954 @default.
• W2108284306 cites W1996458828 @default.
• W2108284306 cites W1997277648 @default.
• W2108284306 cites W1998588782 @default.
• W2108284306 cites W2003009451 @default.
• W2108284306 cites W2006671909 @default.
• W2108284306 cites W2006813481 @default.
• W2108284306 cites W2011124785 @default.
• W2108284306 cites W2011548549 @default.
• W2108284306 cites W2012042329 @default.
• W2108284306 cites W2012519169 @default.
• W2108284306 cites W2014461548 @default.
• W2108284306 cites W2014956686 @default.
• W2108284306 cites W2015893498 @default.
• W2108284306 cites W2016463305 @default.
• W2108284306 cites W2018129134 @default.
• W2108284306 cites W2022944518 @default.
• W2108284306 cites W2032215337 @default.
• W2108284306 cites W2033556279 @default.
• W2108284306 cites W2043976304 @default.
• W2108284306 cites W2044099944 @default.
• W2108284306 cites W2052174005 @default.
• W2108284306 cites W2053780698 @default.
• W2108284306 cites W2054515228 @default.
• W2108284306 cites W2059565225 @default.
• W2108284306 cites W2065237782 @default.
• W2108284306 cites W2066133764 @default.
• W2108284306 cites W2066688538 @default.
• W2108284306 cites W2067143182 @default.
• W2108284306 cites W2068802530 @default.
• W2108284306 cites W2070692721 @default.
• W2108284306 cites W2071651956 @default.
• W2108284306 cites W2073192852 @default.
• W2108284306 cites W2075876711 @default.
• W2108284306 cites W2086444959 @default.
• W2108284306 cites W2095964567 @default.
• W2108284306 cites W2100348082 @default.
• W2108284306 cites W2101474899 @default.
• W2108284306 cites W2102301671 @default.
• W2108284306 cites W2112757583 @default.
• W2108284306 cites W2113095745 @default.
• W2108284306 cites W2131032180 @default.
• W2108284306 cites W2136652160 @default.
• W2108284306 cites W2140419589 @default.
• W2108284306 cites W2147201335 @default.
• W2108284306 cites W2156320702 @default.
• W2108284306 cites W2161541695 @default.
• W2108284306 cites W2165138250 @default.
• W2108284306 cites W2167272429 @default.
• W2108284306 cites W2167955183 @default.
• W2108284306 cites W2330454673 @default.
• W2108284306 cites W2332640098 @default.
• W2108284306 cites W2979039989 @default.
• W2108284306 cites W4243471527 @default.
• W2108284306 cites W4253426594 @default.
• W2108284306 cites W4294109446 @default.
• W2108284306 cites W4328001130 @default.
• W2108284306 doi "https://doi.org/10.1016/j.annemergmed.2010.11.031" @default.
• W2108284306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21306786" @default.
• W2108284306 hasPublicationYear "2011" @default.
• W2108284306 type Work @default.
• W2108284306 sameAs 2108284306 @default.
• W2108284306 citedByCount "20" @default.
• W2108284306 countsByYear W21082843062012 @default.
• W2108284306 countsByYear W21082843062013 @default.
• W2108284306 countsByYear W21082843062014 @default.
• W2108284306 countsByYear W21082843062015 @default.
• W2108284306 countsByYear W21082843062017 @default.
• W2108284306 countsByYear W21082843062019 @default.
• W2108284306 countsByYear W21082843062021 @default.
• W2108284306 crossrefType "journal-article" @default.
• W2108284306 hasAuthorship W2108284306A5048154042 @default.
• W2108284306 hasConcept C118552586 @default.
• W2108284306 hasConcept C126322002 @default.
• W2108284306 hasConcept C141071460 @default.
• W2108284306 hasConcept C2776265017 @default.
• W2108284306 hasConcept C2776884760 @default.
• W2108284306 hasConcept C2777557582 @default.
• W2108284306 hasConcept C2779581417 @default.
• W2108284306 hasConcept C2780011451 @default.
• W2108284306 hasConcept C2780724011 @default.
• W2108284306 hasConcept C2780868729 @default.
• W2108284306 hasConcept C2781362458 @default.
• W2108284306 hasConcept C500558357 @default.
• W2108284306 hasConcept C71924100 @default.

• next